Healthcare Equipment and Supplies
Company Overview of Ethicon Endo-Surgery, Inc.
Ethicon Endo-Surgery, Inc. develops and markets medical devices for minimally invasive and open surgical procedures worldwide. It provides access devices, such as trocars, insufflation needles, and hand assisted and single site laparoscopy devices; clip appliers, including endoscopic rotating multiple clip appliers, open ligation products, and multi-patient use single-clip appliers; and specimen retrieval bags, suturing devices, endoscopic hand instruments, electrosurgical and irrigation products, laparoscopic bipolar forceps, and uterine manipulators. The company offers energy devices, such as curved and long curved shears, blades, open shears, jaw tissue sealers, and curved and straight ti...
4545 Creek Road
Cincinnati, OH 45242-2839
Founded in 1992
Key Executives for Ethicon Endo-Surgery, Inc.
Worldwide Vice President of Research and Development
Vice President of WW Clinical and Regulatory Affairs
Director of Reimbursement and Healthcare Economics
Vice President of U.S. Marketing
Compensation as of Fiscal Year 2014.
Ethicon Endo-Surgery, Inc. Key Developments
Covidien Files Patent Infringement Lawsuit over Ethicon Endo-Surgery, Inc.'s Ultrasonic Surgical Devices
Jun 24 14
Covidien announced that it filed a lawsuit in the U.S. District Court for the District of Connecticut against Ethicon Endo-Surgery, Inc. The lawsuit alleges that Ethicon's latest ultrasonic surgical product, the Harmonic ACE(R)+7, infringes three Covidien patents. The same federal court found that these patents were valid and had been infringed in an earlier lawsuit relating to other Ethicon ultrasonic surgical products. The lawsuit contends that U.S. Patents 6,063,050; 6,468,286; and 6,682,544 are infringed by Ethicon's Harmonic ACE(R)+7 Shears. Ethicon's Harmonic devices were found to infringe the same patents in a prior suit in the same court that resulted in a damages award against Ethicon of more than $175 million, a finding that is currently under appeal. The new suit asks the court to enjoin Ethicon from continuing to make and sell the Harmonic ACE(R)+7 device and to grant damages for the patent infringement.
Ethicon Launches Harmonic Ace(R) +7 Shears with Advanced Hemostasis
May 19 14
Ethicon Endo-Surgery, Inc. announced the launch of HARMONIC ACE(R) +7 Shears with Advanced Hemostasis (HARMONIC ACE(R) +7), the first purely ultrasonic device with a 7 mm sealing indication. HARMONIC ACE(R) +7 combines the precision and multi-functionality expected of HARMONIC(R) with reliable large vessel sealing; a benefit combination that does not exist in any other product, representing a true breakthrough in ultrasonic energy technology. The new device will be featured at The American Society of Colon and Rectal Surgeons (ASCRS) Annual Scientific Meeting in Hollywood, FL this week. The HARMONIC ACE(R) +7 is setting a new standard in ultrasonic energy by demonstrating larger vessel sealing strength using the Advanced Hemostasis mode. Benchtop testing shows: Greater 5 to 7 mm vessel-sealing reliability than LigaSureTM devices1; 140% higher median burst pressure vs LigaSureTM 5 mm Blunt Tip, when sealing 5 to 7 mm vessels in the Advanced Hemostasis mode2; 112% higher median burst pressure vs LigaSure Advance(TM), when sealing 5 to 7 mm vessels in the Advanced Hemostasis mode3. The addition of the 7 mm vessel sealing capability to the HARMONIC ACE(R) +7 makes it an optimal tool for laparoscopic colon surgery. It provides the same precise dissection that I've become accustomed to from the HARMONIC ACE(R) and now with larger vessel sealing capability.
Ethicon Endo-Surgery, Inc. Receives 510 Clearance for New HARMONIC FOCUS+ Shears with Adaptive Tissue Technology
Dec 11 13
Ethicon Endo-Surgery, Inc. announced that HARMONIC FOCUS(R) + Shears with Adaptive Tissue Technology (HARMONIC FOCUS(R) +) has received 510(k) clearance from the U.S. FDA. The HARMONIC FOCUS(R) + is a next generation ultrasonic surgical device that now brings Adaptive Tissue Technology to open procedures while delivering on the HARMONIC(R) promise of precision. This is the fifth 510(k) clearance for the Ethicon Energy portfolio this year. The new HARMONIC FOCUS(R) + leverages the proprietary Adaptive Tissue Technology that was originally introduced in HARMONIC ACE(R) + earlier this year. This technology enables the system to actively sense and adapt to changing tissue conditions and intelligently deliver energy resulting in improved performance with superior precision. In addition, the new slimmer profile is designed to increase speed and visibility, as well as improved dissection. HARMONIC FOCUS(R) + is designed for use in numerous procedures and specialties including ENT and General, enhancing surgeons' ability to handle multiple jobs with superior precision. HARMONIC(R) ultrasonic devices combine precision and multifunctionality: Uniquely designed for precise dissection, sealing and transection, one device enables surgeons to perform multiple jobs without instrument exchanges. HARMONIC(R) technology is the proven leader in advanced energy with more than 16 million procedures worldwide. Devices in the HARMONIC(R) portfolio are used for open and laparoscopic procedures that require precision. The portfolio can be used across a range of surgical specialties: General, Colorectal, Bariatric, Vascular, Gynecology, ENT, Urology, Thoracic, and Plastic and Reconstructive. Click here to learn more. ENSEAL(R) Tissue Sealers consistently cut and seal vessels up to and including 7mm through high uniform compression. Devices in the ENSEAL(R) portfolio are intended for use during both open and laparoscopic surgical procedures where division of vessels, lymphatics and tissue bundles is performed. These surgical specialties include: General, Colorectal, Bariatric, Gynecology, Thoracic, Plastic and Reconstructive, Urology, and ENT.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|